Hospitals | October 18, 2021
GPT Healthcare to go public to fund expansion
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
HTL will build, validate and operate a botulinum manufacturing facility in the US
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
Subscribe To Our Newsletter & Stay Updated
